Skip to main content

Erratum to: Clinical trial and in-vitro study comparing the efficacy of treating bony lesions with allografts versus synthetic or highly-processed xenogeneic bone grafts

  • The original article was published in BMC Musculoskeletal Disorders 2016 17:77

Erratum

After publication of the original article [1], the authors noticed an error in the ‘Methods’ section. Within the ‘Patients’ sub-section, the first item in the list of synthetic or highly processed xenogeneic bone substitutes (SBS) should have been given as Orthoss®, rather than BioOss®. The sentence should therefore have read as follows:

“The following SBS were used: Orthoss® (Geistlich, Wolhusen, Switzerland) in 41.4 %, and at clearly lower percentages, respectively: Norian SRS® (Synthes) (8.6 %), Chronos® (Synthes) (1.7 %), Atlantik® (Argomedical) (2.6 %), Alaska® (Argomedical) (0.9 %), Endobone® (Biomet) (4.3 %), Pyrost® (Stryker) (0.9 %), Nanostim® (Medtronic) (37.1 %), Actifuse® (Baxter) (0.9 %), Tutobone® (Novomedics) (0.9 %) and PerOssal® (Botiss) (0.9 %).”

Reference

  1. 1.

    Kubosch EJ, Bernstein A, Wolf L, Fretwurst T, Nelson K, Schmal H. Clinical trial and in-vitro study comparing the efficacy of treating bony lesions with allografts versus synthetic or highlyprocessed xenogeneic bone grafts. BMC Musc Disord. 2016;17:77.

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Hagen Schmal.

Additional information

The online version of the original article can be found under doi:10.1186/s12891-016-0930-1.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kubosch, E.J., Bernstein, A., Wolf, L. et al. Erratum to: Clinical trial and in-vitro study comparing the efficacy of treating bony lesions with allografts versus synthetic or highly-processed xenogeneic bone grafts. BMC Musculoskelet Disord 17, 118 (2016). https://doi.org/10.1186/s12891-016-0976-0

Download citation